Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sandra A Springer

Showing results (81-90 of 121) with videos related to

Pageof 13
Sort By:
The American Journal on Addictions|June 2, 2022
Gender differences among persons entering medication treatment for opioid use disorder in the communityAngela Di Paola, Noor Taweh, Breanne E Biondi, et al.
Open Forum Infectious Diseases|August 25, 2021
A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease OutcomesKatelyn F McNamara, Breanne E Biondi, Raúl U Hernández-Ramírez, et al.
Journal of Substance Abuse Treatment|May 7, 2017
Corrigendum to 'An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone' [Journal of Substance Abuse Treatment 47 (2014) 35-40]Panagiotis Vagenas, Angela Di Paola, Maua Herme, et al.
AIDS and Behavior|November 13, 2012
Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite studyArchana Krishnan, Jeffrey A Wickersham, Ehsan Chitsaz, et al.
AJOB Empirical Bioethics|December 29, 2015
An exploratory study of therapeutic misconception among incarcerated clinical trial participantsPaul P Christopher, Michael D Stein, Sandra A Springer, et al.
Journal of Substance Abuse Treatment|February 9, 2018
A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in UkraineRuthanne Marcus, Martha J Bojko, Alyona Mazhnaya, et al.
Open Forum Infectious Diseases|April 25, 2025
Pilot Findings From the First Legalized Mobile Retail Pharmacy Clinic in the United States for Infectious Disease Treatment and Prevention Tailored to Reach People Who Use DrugsAdati Tarfa, Angela Di Paola, Cynthia A Frank, et al.
AIDS and Behavior|December 19, 2007
Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapyDuncan Smith-Rohrberg Maru, R Douglas Bruce, Mary Walton, et al.
International Journal of Prisoner Health|December 31, 2013
Partner violence and health among HIV-infected jail detaineesJaimie P Meyer, Jeffrey A Wickersham, Jeannia J Fu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replicationFrederick L Altice, Jo Anne Mezger, John Hodges, et al.
Pageof 13

Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
The American Journal on Addictions|June 2, 2022
Gender differences among persons entering medication treatment for opioid use disorder in the communityAngela Di Paola, Noor Taweh, Breanne E Biondi, et al.
Open Forum Infectious Diseases|August 25, 2021
A Systematic Review and Meta-Analysis of Studies Evaluating the Effect of Medication Treatment for Opioid Use Disorder on Infectious Disease OutcomesKatelyn F McNamara, Breanne E Biondi, Raúl U Hernández-Ramírez, et al.
Journal of Substance Abuse Treatment|May 7, 2017
Corrigendum to 'An evaluation of hepatic enzyme elevations among HIV-infected released prisoners enrolled in two randomized placebo-controlled trials of extended release naltrexone' [Journal of Substance Abuse Treatment 47 (2014) 35-40]Panagiotis Vagenas, Angela Di Paola, Maua Herme, et al.
AIDS and Behavior|November 13, 2012
Post-release substance abuse outcomes among HIV-infected jail detainees: results from a multisite studyArchana Krishnan, Jeffrey A Wickersham, Ehsan Chitsaz, et al.
AJOB Empirical Bioethics|December 29, 2015
An exploratory study of therapeutic misconception among incarcerated clinical trial participantsPaul P Christopher, Michael D Stein, Sandra A Springer, et al.
Journal of Substance Abuse Treatment|February 9, 2018
A qualitative assessment of attitudes about and preferences for extended-release naltrexone, a new pharmacotherapy to treat opioid use disorders in UkraineRuthanne Marcus, Martha J Bojko, Alyona Mazhnaya, et al.
Open Forum Infectious Diseases|April 25, 2025
Pilot Findings From the First Legalized Mobile Retail Pharmacy Clinic in the United States for Infectious Disease Treatment and Prevention Tailored to Reach People Who Use DrugsAdati Tarfa, Angela Di Paola, Cynthia A Frank, et al.
AIDS and Behavior|December 19, 2007
Initiation, adherence, and retention in a randomized controlled trial of directly administered antiretroviral therapyDuncan Smith-Rohrberg Maru, R Douglas Bruce, Mary Walton, et al.
International Journal of Prisoner Health|December 31, 2013
Partner violence and health among HIV-infected jail detaineesJaimie P Meyer, Jeffrey A Wickersham, Jeannia J Fu, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 25, 2004
Developing a directly administered antiretroviral therapy intervention for HIV-infected drug users: implications for program replicationFrederick L Altice, Jo Anne Mezger, John Hodges, et al.
Pageof 13